SEC-sourced researchBeta
DNTH
Dianthus Therapeutics, Inc. /DE/
Company comparison ↗
Data passport
- CIK
- 0001690585
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Sep 18, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 6,235,000.0000 | Mar 9, 2026 |
| December 2025 | 2,036,000.0000 | Mar 9, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 2,036,000.0000 | -162,337,000.0000 | -129,060,000.0000 | 530,922,000.0000 | 37,521,000.0000 | Mar 9, 2026 |
| December 2024 | 6,235,000.0000 | -84,969,000.0000 | -78,180,000.0000 | 374,008,000.0000 | 21,531,000.0000 | Mar 9, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $2.04M | December 2025 | Mar 9, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $6.24M | December 2024 | Mar 9, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$162.34M | December 2025 | Mar 9, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$129.06M | December 2025 | Mar 9, 2026 | 10-K |
| Total assetsAssets | $530.92M | December 2025 | Mar 9, 2026 | 10-K |
| Total liabilitiesLiabilities | $37.52M | December 2025 | Mar 9, 2026 | 10-K |
New filings
- 4DNTH · Dianthus Therapeutics, Inc. /DE/Sep 18, 2026 · Other
- S-3ASRDNTH · Dianthus Therapeutics, Inc. /DE/Sep 18, 2026 · Other
- 144DNTH · Dianthus Therapeutics, Inc. /DE/Sep 17, 2026 · Other
- 4DNTH · Dianthus Therapeutics, Inc. /DE/Sep 3, 2026 · Other
- 144DNTH · Dianthus Therapeutics, Inc. /DE/Sep 1, 2026 · Other
- 10-KDNTH · DIANTHUS THERAPEUTICS, INC. /DE/Mar 9, 2026 · Annual